Results 821-840 of 3,336 for speaker:Kate O'Connell
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 21 - Accounts of the National Treasury Management Agency
National Treasury Management Agency Financial Statements 2018 (4 Jul 2019) Kate O'Connell: How were drugs authorised before the HPRA was established? Hopefully Mr. Breen will know that answer. Did we just go with the UK?
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 21 - Accounts of the National Treasury Management Agency
National Treasury Management Agency Financial Statements 2018 (4 Jul 2019) Kate O'Connell: Before the thalidomide matter, there must have been something.
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 21 - Accounts of the National Treasury Management Agency
National Treasury Management Agency Financial Statements 2018 (4 Jul 2019) Kate O'Connell: The drugs advisory board was essentially a precursor to the HPRA.
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 21 - Accounts of the National Treasury Management Agency
National Treasury Management Agency Financial Statements 2018 (4 Jul 2019) Kate O'Connell: The latter has international standing. What have we learned from the time in question, particularly regarding thalidomide? I am a chemist by profession so I am aware of how the thalidomide issue arose. The isomer changed and had a profoundly different effect. The regulations and hoops companies have to go through were really reinforced as a result of the thalidomide issue. The Swiss...
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 21 - Accounts of the National Treasury Management Agency
National Treasury Management Agency Financial Statements 2018 (4 Jul 2019) Kate O'Connell: That it hits the agency.
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 21 - Accounts of the National Treasury Management Agency
National Treasury Management Agency Financial Statements 2018 (4 Jul 2019) Kate O'Connell: Aulin was available in Ireland but not in the UK. I was actually working in the UK at the time. Are the learnings a matter for the Department?
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 21 - Accounts of the National Treasury Management Agency
National Treasury Management Agency Financial Statements 2018 (4 Jul 2019) Kate O'Connell: It was well documented in the UK that people were not to be on Aulin, and it was taken off. We seem to have been so far behind the UK in terms of our learnings. I am assuming Mr. Breen's answer will be the same as with thalidomide.
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 21 - Accounts of the National Treasury Management Agency
National Treasury Management Agency Financial Statements 2018 (4 Jul 2019) Kate O'Connell: It is the same answer but Mr. Breen is still the person who has to come in here and answer the questions as to why there is so much money being spent.
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 21 - Accounts of the National Treasury Management Agency
National Treasury Management Agency Financial Statements 2018 (4 Jul 2019) Kate O'Connell: In the case of Pandemrix, the emergency, the epidemic or potential epidemic – I believe it was swine flu – the State took on the liability associated with the drug. It had not gone through the trial process. Does the Department have to provide the learning from that experience?
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 21 - Accounts of the National Treasury Management Agency
National Treasury Management Agency Financial Statements 2018 (4 Jul 2019) Kate O'Connell: The best effect of not going to the trial process is the cost. The question is about the effect on the children's lives and those of their families. Turning to claims against the State, 3% of people go to court.
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 21 - Accounts of the National Treasury Management Agency
National Treasury Management Agency Financial Statements 2018 (4 Jul 2019) Kate O'Connell: The proportion of claims that are related to obstetrics and gynaecology is massive. Is it 60%?
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 21 - Accounts of the National Treasury Management Agency
National Treasury Management Agency Financial Statements 2018 (4 Jul 2019) Kate O'Connell: So, half of all-----
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 21 - Accounts of the National Treasury Management Agency
National Treasury Management Agency Financial Statements 2018 (4 Jul 2019) Kate O'Connell: Does the 50% encompassing obstetrics and gynaecology cover the claims of the mother and baby or is that figure only for mothers' claims?
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 21 - Accounts of the National Treasury Management Agency
National Treasury Management Agency Financial Statements 2018 (4 Jul 2019) Kate O'Connell: Does the 50% for obstetrics and gynaecology cover the babies and the mothers?
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 21 - Accounts of the National Treasury Management Agency
National Treasury Management Agency Financial Statements 2018 (4 Jul 2019) Kate O'Connell: What I am getting at is why people do not go to court. I am all for mediation but are a disproportionate amount of affected women not going to court? Mr. Kelly and Mr. Lynch spoke compassionately earlier but the reality is that if a women suffers damage during a birth that has aspects of negligence, if she was to go to court, like the 221 women who were misdiagnosed in the CervicalCheck...
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 21 - Accounts of the National Treasury Management Agency
National Treasury Management Agency Financial Statements 2018 (4 Jul 2019) Kate O'Connell: That is a very general statement. I have spoken to women who have specifically said that they would never go to the court process because they do not want their wider family or the wider community knowing the intimate details of their lives as a result of medical negligence.
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 21 - Accounts of the National Treasury Management Agency
National Treasury Management Agency Financial Statements 2018 (4 Jul 2019) Kate O'Connell: There are such women. There is no "perhaps" about it.
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 21 - Accounts of the National Treasury Management Agency
National Treasury Management Agency Financial Statements 2018 (4 Jul 2019) Kate O'Connell: We want to spare women the court experience, as Mr. Breen said. There is a process preceding mediation. Consider the case of a woman who has an incident at birth and we will leave the infant out of the situation, we are only dealing with the mother. There are experts on the HSE side and the mother's side. I understand from the health committee meeting yesterday on the tribunal for the 221...
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 21 - Accounts of the National Treasury Management Agency
National Treasury Management Agency Financial Statements 2018 (4 Jul 2019) Kate O'Connell: It happens on both sides.
- Public Accounts Committee: 2017 Annual Report of the Comptroller and Auditor General
Chapter 21 - Accounts of the National Treasury Management Agency
National Treasury Management Agency Financial Statements 2018 (4 Jul 2019) Kate O'Connell: Everything is in duplicate. That is my point.